South Egypt Cancer Institute

NCT05348408

Phase 2, Completed, 2022, 62 people, 27 Apr 2022, clinicaltrials.gov

NCT04342065

Phase 2/3, Completed, 2019, 200 people, 10 Apr 2020, clinicaltrials.gov

NCT03060070

Collaborator, Phase 2/3, Completed, 2017, 90 people, 23 Feb 2017, clinicaltrials.gov